Cargando…
N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis via Differentially Regulating Ubiquitination of Targets
BACKGROUND: A tremendous amount of studies have suggested that post-translational modifications (PTMs) play pivotal roles during tumorigenesis. Compared to other PTMs, lipid modification is less studied. Recently, N-myristoylation, one type of lipid modification, has been paid attention to the field...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201403/ https://www.ncbi.nlm.nih.gov/pubmed/34136404 http://dx.doi.org/10.3389/fonc.2021.681366 |
_version_ | 1783707811269574656 |
---|---|
author | Zhu, Guoqing Wang, Feng Li, Haojie Zhang, Xiao Wu, Qi Liu, Ya Qian, Mingping Guo, Susu Yang, Yueyue Xue, Xiangfei Sun, Fenyong Qiao, Yongxia Pan, Qiuhui |
author_facet | Zhu, Guoqing Wang, Feng Li, Haojie Zhang, Xiao Wu, Qi Liu, Ya Qian, Mingping Guo, Susu Yang, Yueyue Xue, Xiangfei Sun, Fenyong Qiao, Yongxia Pan, Qiuhui |
author_sort | Zhu, Guoqing |
collection | PubMed |
description | BACKGROUND: A tremendous amount of studies have suggested that post-translational modifications (PTMs) play pivotal roles during tumorigenesis. Compared to other PTMs, lipid modification is less studied. Recently, N-myristoylation, one type of lipid modification, has been paid attention to the field of cancer. However, whether and how N-myristoylation exerts its roles in liver tumorigenesis still remains unclear. METHODS: Parallel reaction monitoring (PRM) was conducted to evaluate the expression of protein modification enzymes in paired tissues. Liver conditionally knocking NMT1 out mice model was used to assess the critical roles of N-myristoylation during liver tumorigenesis. Proteomics isobaric tags for relative and absolute quantification (iTraq) was performed to identify proteins that changed while NMT1 was knocked down. The click chemistry assay was used to evaluate the N-myristoylation levels of proteins. RESULTS: Here, N-myristolyation and its enzyme NMT1, but not NMT2, were found to be critical in liver cancer. Two categories of proteins, i.e., N-myristolyation down-regulated proteins (NDP, including LXN, RPL29, and FAU) and N-myristolyation up-regulated proteins (NUP, including AHSG, ALB, and TF), were revealed negatively and positively regulated by NMT1, respectively. Both NDP and NUP could be N-myristolyated by NMT1 indispensable of POTEE. However, N-myristolyation decreased and increased stability of NDP and NUP, respectively. Mechanistically, NDP-specific binding protein RPL7A facilitated HIST1H4H, which has ubiquitin E3 ligase function, to ubiquitinate NDP. By contrast, NUP-specific binding protein HBB prevented NUP from ubiquitination by HIST1H4H. Notably, function of RPL7A and HBB was all NMT1-dependent. Moreover, NDP suppressed while NUP stimulated transformative phenotypes. Clinically, higher levels of NMT1 and NUP with lower levels of NDP had worse prognostic outcome. CONCLUSION: Collectively, N-myristolyation by NMT1 suppresses anti-tumorigenic NDP, whereas it stimulates pro-tumorigenic NUP by interfering their ubiquitination to finally result in a pro-tumorigenic outcome in liver cancer. Targeting N-myristolyation and NMT1 might be helpful to treat liver cancer. |
format | Online Article Text |
id | pubmed-8201403 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82014032021-06-15 N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis via Differentially Regulating Ubiquitination of Targets Zhu, Guoqing Wang, Feng Li, Haojie Zhang, Xiao Wu, Qi Liu, Ya Qian, Mingping Guo, Susu Yang, Yueyue Xue, Xiangfei Sun, Fenyong Qiao, Yongxia Pan, Qiuhui Front Oncol Oncology BACKGROUND: A tremendous amount of studies have suggested that post-translational modifications (PTMs) play pivotal roles during tumorigenesis. Compared to other PTMs, lipid modification is less studied. Recently, N-myristoylation, one type of lipid modification, has been paid attention to the field of cancer. However, whether and how N-myristoylation exerts its roles in liver tumorigenesis still remains unclear. METHODS: Parallel reaction monitoring (PRM) was conducted to evaluate the expression of protein modification enzymes in paired tissues. Liver conditionally knocking NMT1 out mice model was used to assess the critical roles of N-myristoylation during liver tumorigenesis. Proteomics isobaric tags for relative and absolute quantification (iTraq) was performed to identify proteins that changed while NMT1 was knocked down. The click chemistry assay was used to evaluate the N-myristoylation levels of proteins. RESULTS: Here, N-myristolyation and its enzyme NMT1, but not NMT2, were found to be critical in liver cancer. Two categories of proteins, i.e., N-myristolyation down-regulated proteins (NDP, including LXN, RPL29, and FAU) and N-myristolyation up-regulated proteins (NUP, including AHSG, ALB, and TF), were revealed negatively and positively regulated by NMT1, respectively. Both NDP and NUP could be N-myristolyated by NMT1 indispensable of POTEE. However, N-myristolyation decreased and increased stability of NDP and NUP, respectively. Mechanistically, NDP-specific binding protein RPL7A facilitated HIST1H4H, which has ubiquitin E3 ligase function, to ubiquitinate NDP. By contrast, NUP-specific binding protein HBB prevented NUP from ubiquitination by HIST1H4H. Notably, function of RPL7A and HBB was all NMT1-dependent. Moreover, NDP suppressed while NUP stimulated transformative phenotypes. Clinically, higher levels of NMT1 and NUP with lower levels of NDP had worse prognostic outcome. CONCLUSION: Collectively, N-myristolyation by NMT1 suppresses anti-tumorigenic NDP, whereas it stimulates pro-tumorigenic NUP by interfering their ubiquitination to finally result in a pro-tumorigenic outcome in liver cancer. Targeting N-myristolyation and NMT1 might be helpful to treat liver cancer. Frontiers Media S.A. 2021-05-31 /pmc/articles/PMC8201403/ /pubmed/34136404 http://dx.doi.org/10.3389/fonc.2021.681366 Text en Copyright © 2021 Zhu, Wang, Li, Zhang, Wu, Liu, Qian, Guo, Yang, Xue, Sun, Qiao and Pan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Zhu, Guoqing Wang, Feng Li, Haojie Zhang, Xiao Wu, Qi Liu, Ya Qian, Mingping Guo, Susu Yang, Yueyue Xue, Xiangfei Sun, Fenyong Qiao, Yongxia Pan, Qiuhui N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis via Differentially Regulating Ubiquitination of Targets |
title | N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis via Differentially Regulating Ubiquitination of Targets |
title_full | N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis via Differentially Regulating Ubiquitination of Targets |
title_fullStr | N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis via Differentially Regulating Ubiquitination of Targets |
title_full_unstemmed | N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis via Differentially Regulating Ubiquitination of Targets |
title_short | N-Myristoylation by NMT1 Is POTEE-Dependent to Stimulate Liver Tumorigenesis via Differentially Regulating Ubiquitination of Targets |
title_sort | n-myristoylation by nmt1 is potee-dependent to stimulate liver tumorigenesis via differentially regulating ubiquitination of targets |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201403/ https://www.ncbi.nlm.nih.gov/pubmed/34136404 http://dx.doi.org/10.3389/fonc.2021.681366 |
work_keys_str_mv | AT zhuguoqing nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets AT wangfeng nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets AT lihaojie nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets AT zhangxiao nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets AT wuqi nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets AT liuya nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets AT qianmingping nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets AT guosusu nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets AT yangyueyue nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets AT xuexiangfei nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets AT sunfenyong nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets AT qiaoyongxia nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets AT panqiuhui nmyristoylationbynmt1ispoteedependenttostimulatelivertumorigenesisviadifferentiallyregulatingubiquitinationoftargets |